drugset / Trial / NCT04941118

Myofascial Pain Syndrome and Dextrose Prolotherapy

NCT04941118

Phase 4 Unknown 60 enrolled Mustafa Kemal University
RandomizedParallel-groupSingle-blindTreatment

Summary

Myofascial pain syndrome is characterized by the presence of hypersensitive points called trigger points that cause pain, tenderness, spasm, stiffness, limitation of movement, weakness, taut band within the muscle, and pain reflected by pressing in a muscle group or a single muscle. Prolotherapy is a regenerative treatment method in the treatment of chronic musculoskeletal pain, in which an irritating solution is injected, often hypertonic dextrose, into painful ligament and tendon attachments and adjacent joint spaces. In this study, it was aimed to examine the effect of prolotherapy application on pain, neck range of motion and neck disability in women with myofascial pain syndrome.

Timeline

Start
2021-07-15
Primary completion
2021-12-30
Completion
2021-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dextrose Unknown 5 % Other
Comparator Lidocaine Other / unclassified 2 % Other

Indications

No indication recorded.